109 related articles for article (PubMed ID: 21933645)
1. Concurrent basal cell and squamous cell carcinomas associated with hydroxyurea therapy.
Radić J; Batinac T; Hadžisejdić I; Načinović-Duletić A; Valković T; Jonjić N
Acta Dermatovenerol Croat; 2011; 19(3):183-6. PubMed ID: 21933645
[TBL] [Abstract][Full Text] [Related]
2. [Multiple skin and mouth squamous cell carcinomas related to long-term treatment with hydroxyurea].
Estève E; Georgescu V; Heitzmann P; Martin L
Ann Dermatol Venereol; 2001 Sep; 128(8-9):919-21. PubMed ID: 11590345
[TBL] [Abstract][Full Text] [Related]
3. Oral squamous cell carcinoma during long-term treatment with hydroxyurea.
De Benedittis M; Petruzzi M; Giardina C; Lo Muzio L; Favia G; Serpico R
Clin Exp Dermatol; 2004 Nov; 29(6):605-7. PubMed ID: 15550132
[TBL] [Abstract][Full Text] [Related]
4. Multiple skin cancers associated with hydroxyurea therapy.
Best PJ; Petitt RM
Mayo Clin Proc; 1998 Oct; 73(10):961-3. PubMed ID: 9787746
[TBL] [Abstract][Full Text] [Related]
5. Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment.
Salmon-Ehr V; Grosieux C; Potron G; Kalis B
Dermatology; 1998; 196(2):274. PubMed ID: 9568428
[No Abstract] [Full Text] [Related]
6. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy.
Weinstock MA; Coulter S; Bates J; Bogaars HA; Larson PL; Burmer GC
Arch Dermatol; 1995 Jun; 131(6):701-4. PubMed ID: 7778923
[TBL] [Abstract][Full Text] [Related]
7. Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea.
De Simone C; Guerriero C; Guidi B; Rotoli M; Venier A; Tartaglione R
Eur J Dermatol; 1998 Mar; 8(2):114-5. PubMed ID: 9649662
[TBL] [Abstract][Full Text] [Related]
8. Multiple skin tumors on light-exposed areas during long-term treatment with hydroxyurea.
Papi M; Didona B; DePità O; Abruzzese E; Stasi R; Papa G; Cavalieri R
J Am Acad Dermatol; 1993 Mar; 28(3):485-6. PubMed ID: 8445067
[No Abstract] [Full Text] [Related]
9. Hydroxyurea-associated squamous dysplasia.
Sanchez-Palacios C; Guitart J
J Am Acad Dermatol; 2004 Aug; 51(2):293-300. PubMed ID: 15280852
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus in cutaneous squamous cell carcinoma and cervix of a patient with psoriasis and extensive ultraviolet radiation exposure.
Rust A; McGovern RM; Gostout BS; Persing DH; Pittelkow MR
J Am Acad Dermatol; 2001 Apr; 44(4):681-6. PubMed ID: 11260548
[TBL] [Abstract][Full Text] [Related]
11. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
Oskay T; Kutluay L; Ozyilkan O
Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
[TBL] [Abstract][Full Text] [Related]
12. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous side effects of hydroxyurea treatment for polycythemia vera].
Hoff NP; Akanay-Diesel S; Pippirs U; Schulte KW; Hanneken S
Hautarzt; 2009 Oct; 60(10):783-7. PubMed ID: 19756436
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
[TBL] [Abstract][Full Text] [Related]
15. The cutaneous side-effects of hydroxyurea.
Young HS; Khan AS; Kendra JR; Coulson IH
Clin Lab Haematol; 2000 Aug; 22(4):229-32. PubMed ID: 11012636
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
[TBL] [Abstract][Full Text] [Related]
17. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
[TBL] [Abstract][Full Text] [Related]
18. [Dermatologic complications of long-term hydroxyurea therapy].
Mokni S; Fetoui Ghariani N; Aounallah A; Fathallah N; Boussofara L; Saidi W; Ben Salem C; Sriha B; Belajouza C; Denguezli M; Ghariani N; Nouira R
Therapie; 2017 Jun; 72(3):391-394. PubMed ID: 27912970
[No Abstract] [Full Text] [Related]
19. Association of cutaneous side-effects of hydroxyurea and neuroendocrine carcinoma.
Bouldouyre MA; Avril MF; Gaulier A; Sigal-Grinberg M
Eur J Dermatol; 2005; 15(4):268-70. PubMed ID: 16048756
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
